Comparing brief-intensive cognitive behavioral therapy with weekly therapy for anxiety disorders
Fast Recovery from Anxiety-related Disorders: Brief-intensive CBT Versus Once-weekly CBT
This study is testing whether a fast-paced, intensive form of cognitive behavioral therapy can help adults with anxiety disorders feel better compared to the traditional weekly therapy sessions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Locations | 6 sites (Amstelveen and 5 other locations) |
| Trial ID | NCT05942391 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of brief-intensive cognitive behavioral therapy (CBT) against traditional weekly CBT in adults with anxiety-related disorders. Participants will undergo either 16 sessions of CBT in a two-week period followed by four follow-up sessions, or 20 weekly sessions of CBT over six months. The study will assess improvements in functioning across various domains, including work and social interactions, over the course of one year. This multicenter, randomized controlled trial seeks to provide evidence for the potential benefits of a more intensive treatment approach.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 who are seeking mental health care for anxiety-related disorders such as panic disorder, agoraphobia, or PTSD.
Not a fit: Patients requiring emergency mental health care or those with significant cognitive limitations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to faster recovery times and improved functioning for patients with anxiety-related disorders.
How similar studies have performed: While some institutions have implemented brief-intensive CBT, there is insufficient evidence from previous studies to fully justify its effectiveness compared to traditional methods.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Age 18 years or older; Reaching out for mental health care for one of the following disorders: panic disorder, agoraphobia, generalised anxiety disorder, social anxiety disorder, posttraumatic stress disorder, obsessive-compulsive disorder, health anxiety disorder. Exclusion Criteria: * Is in need of emergency mental health care * Has insufficient language skills in Dutch * Has evident cognitive limitations * Has had changes in the use of medication during the last 3 months.
Where this trial is running
Amstelveen and 5 other locations
- GGZ inGeest, polikliniek Angst & Dwang, locatie Amstelmere — Amstelveen, Netherlands (Recruiting)
- GGZ inGeest, polikliniek Angst & Dwang, locatie De Nieuwe Valerius — Amsterdam, Netherlands (Recruiting)
- GGZ inGeest, polikliniek Angst & Dwang, locatie Zuiderpoort — Haarlem, Netherlands (Recruiting)
- GGZ Centraal, Algemeen Specialistische Polikliniek — Hilversum, Netherlands (Recruiting)
- GGZ inGeest, polikliniek Angst & Dwang, locatie Spaarnepoort — Hoofddorp, Netherlands (Recruiting)
- Altrecht Academisch Angstcentrum — Utrecht, Netherlands (Recruiting)
Study contacts
- Study coordinator: Lisa de Koning, MSc
- Email: l.dekoning1@amsterdamumc.nl
- Phone: +31 207884666
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.